Literature DB >> 7305984

Removal of glycosaminoglycans from cultures of human skin fibroblasts.

P J Gill, J Adler, C K Silbert, J E Silbert.   

Abstract

Early-passage human skin fibroblasts were grown as monolayers for 2-3 days in minimum essential medium containing [35S]sulphate, [3H]glucosamine, [3H]fucose, [3H]proline or [3H]leucine to label proteoglycans, glycoproteins or collagen and other proteins. A crude enzyme preparation obtained from a supernatant from sonicated freeze-dried Flavobacter heparinum was added to the cell monolayers. This treatment removed most of the 35S-labelled glycosaminoglycans, with no appreciable removal of the 3H-labelled proteins or 3H-labelled glycoproteins. The cells remained attached and viable as a monolayer. The formation of 35S-labelled glycosaminoglycans was examined after pretreating cultures with crude F. heparinum enzyme, followed by addition of fresh growth medium containing [35S]sulphate. The F. heparinum enzyme did not significantly alter the amount or type of 35S-labelled glycosaminoglycans produced. Thus F. heparinum enzyme can be used to provide cultured-cell monolayers depleted of surface glycosaminoglycans. These cells remain attached, viable and subsequently synthesize normal amounts and type of glycosaminoglycans.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305984      PMCID: PMC1162744          DOI: 10.1042/bj1940299

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Production and secretion of chondroitin sulfates and dermatan sulfate by established mammalian cell lines.

Authors:  H Saito; B G Uzman
Journal:  Biochem Biophys Res Commun       Date:  1971-05-21       Impact factor: 3.575

3.  A comparative study of glycoproteins from the surface of control and Rous sarcoma virus transformed hamster cells.

Authors:  C A Buck; M C Glick; L Warren
Journal:  Biochemistry       Date:  1970-11-10       Impact factor: 3.162

4.  The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide.

Authors:  J C Fratantoni; C W Hall; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

5.  The enzymatic degradation of heparin and heparitin sulfate. I. The fractionation of a crude heparinase from flavobacteria.

Authors:  A Linker; P Hovingh
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

6.  Tadpole collagenase. Preparation and purification.

Authors:  Y Nagai; C M Lapiere; J Gross
Journal:  Biochemistry       Date:  1966-10       Impact factor: 3.162

7.  Heparan sulfates of cultured cells. I. Membrane-associated and cell-sap species in Chinese hamster cells.

Authors:  P M Kraemer
Journal:  Biochemistry       Date:  1971-04-13       Impact factor: 3.162

8.  Stimulation of chondromucoprotein synthesis in chondrocytes by extracellular chondromucoprotein.

Authors:  Z Nevo; A Dorfman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

9.  The extracellular matrix of the regenerating newt limb: synthesis and removal of hyaluronate prior to differentiation.

Authors:  B P Toole; J Gross
Journal:  Dev Biol       Date:  1971-05       Impact factor: 3.582

10.  Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell cultures.

Authors:  V Buonassisi; M Root
Journal:  Biochim Biophys Acta       Date:  1975-03-14
View more
  14 in total

1.  Glycosaminoglycan metabolism before molecular biology: reminiscences of our early work.

Authors:  Jeremiah E Silbert
Journal:  Glycoconj J       Date:  2009-09-02       Impact factor: 2.916

2.  Cell surface glycosaminoglycans are not involved in the adherence of Helicobacter pylori to cultured Hs 198.St human gastric cells, Hs 746T human gastric adenocarcinoma cells, or HeLa cells.

Authors:  H Kawasaki; G Sugumaran; J E Silbert
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

3.  Production of proteoglycans by human lung fibroblasts (IMR-90) maintained in a low concentration of serum.

Authors:  K G Vogel; R E Sapién
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

4.  Specific association of iduronic acid-rich dermatan sulphate with the extracellular matrix of human skin fibroblasts cultured on collagen gels.

Authors:  J T Gallagher; N Gasiunas; S L Schor
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

5.  Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.

Authors:  K Shimada; T Ozawa
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

6.  Glycosaminoglycans on fibroblasts accelerate thrombin inhibition by protease nexin-1.

Authors:  D H Farrell; D D Cunningham
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

7.  Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells.

Authors:  K Shimada; P J Gill; J E Silbert; W H Douglas; B L Fanburg
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites.

Authors:  M Simionescu; N Simionescu; J E Silbert; G E Palade
Journal:  J Cell Biol       Date:  1981-09       Impact factor: 10.539

9.  Integrity of the pericellular fibronectin matrix of fibroblasts is independent of sulfated glycosaminoglycans.

Authors:  K Hedman; T Vartio; S Johansson; L Kjellén; M Höök; A Linker; E M Salonen; A Vaheri
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin.

Authors:  J Laterra; J E Silbert; L A Culp
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.